Community/Retail

The meeting will take place May 16-19, 2015, at the Roosevelt New Orleans hotel in New Orleans, LA.

A drug typically used to treat herpes may reduce HIV-1 levels, even in those who don't have herpes.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about how medication synchronization programs help pharmacists achieve adherence goals.

R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about how Medicare Part B, C, and D-compliant practices change overall pharmacy practice.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about what pharmacists can do to promote medication synchronization programs.

R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about how pharmacists can ensure they are compliant with Medicare Part B, C, and D standards.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about the role of technology in medication synchronization programs.

R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about how pharmacy compliance requirements differ across the 3 Medicare plans.

The company will select research partners for the project from among researchers based in Japan.

Retosiban is being developed as a potential treatment to improve neonatal outcomes of babies born to women in spontaneous preterm labor by prolonging the time to delivery.

Ignyta has acquired the worldwide rights and assets relating to Teva's 4 targeted oncology development programs.

Two former members of the Allergan Board of Directors have been named to the Actavis Board of Directors.

Actavis plc has completed the acquisition of Allergan, Inc, in a cash and equity transaction valued at approximately $70.5 billion.

Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund.

By illuminating the challenges of prescribing and dispensing opioids, the groups aim to prevent the misuse and diversion of controlled substances while ensuring access to the medicines for patients with legitimate needs.

The agency is slated to review the new drug application within a 6-month timeframe.

Two heads-or 3 in this case-are better than 1.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about how medication synchronization improves patient care and brings the pharmacy more business.

R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about why Medicare Part B, C, and D standards are so important to a pharmacy's business.

Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about factors pharmacists should consider when introducing medication synchronization programs in their pharmacies.

The 2015 American College of Cardiology Annual Scientific Session and Expo featured the latest discoveries in cardiovascular research.

A 20 mg dose of vilazodone HCl (Viibryd) is now available in pharmacies to treat adult patients with major depressive disorder.

Following accusations of conspiracy, a Mississippi pharmacist will pay the federal government $2 million as part of a plea deal.

The computer will replace most of what the health care team does.

The letter was written in response to an opinion column published on March 11, 2015, titled "The Legal Drug Epidemic."

When you put a face on the impact of high-cost specialty drugs, it is hard to ignore the expenses.

The National Association of Chain Drug Stores announces the expansion and acquisition of a certificate program designed to provide training for pharmacists to administer point-of-care testing and other health assessments in pharmacies.

Hospitals with lower rates of 30-day unplanned readmissions tend to have better Facebook ratings than those with higher readmission rates.